Recall D-0806-2026

US Class II Ongoing · initiated 2026-08-06

Recalling firm

Baxter Healthcare Corporation, IL

Product

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

Reason for recall

CGMP Deviations

← All recalls